# The Impact of MS-20 on Gut Microbiota Composition in Adult Individuals

> **NCT04674839** · NA · COMPLETED · sponsor: **Microbio Co Ltd** · enrollment: 100 (actual)

## Conditions studied

- Microbiota

## Interventions

- **DRUG:** MS-20
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04674839
- **Lead sponsor:** Microbio Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-18
- **Primary completion:** 2020-09-04
- **Final completion:** 2020-11-20
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04674839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04674839, "The Impact of MS-20 on Gut Microbiota Composition in Adult Individuals". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT04674839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*